Table 2 Treatment Outcomes
Outcome | All Patients (N = 172) | HBsAg/HBcAb Negative (n = 119) | HBsAg/HBcAb Positive (n = 53) | P | |||
|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | ||
Response | |||||||
CR/PR | 122 | 71 | 92 | 77 | 30 | 57 | 0.022 |
PD/RD | 29 | 17 | 16 | 14 | 13 | 24 | |
Disease relapse | 21 | 12 | 11 | 9 | 10 | 19 | |
Predicted 3-year PFS (± SE) | 67% (± 4%) | 76% (± 4%) | 52% (± 8%) | 0.009 | |||
Death | 16 | 9 | 7 | 6 | 9 | 17 | 0.21 |
Predicted 3-year OS (± SE) | 88% (± 3%) | 93% (± 3%) | 77% (± 7%) | 0.012 | |||